JMP Securities Reiterates Market Outperform on OrthoPediatrics, Maintains $50 Price Target
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst David Turkaly has reiterated a Market Outperform rating for OrthoPediatrics (NASDAQ:KIDS) and maintained a $50 price target.
September 13, 2024 | 2:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has reiterated its Market Outperform rating for OrthoPediatrics, maintaining a $50 price target, indicating confidence in the company's future performance.
The reiteration of a Market Outperform rating and a maintained price target of $50 by JMP Securities suggests a positive outlook for OrthoPediatrics. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100